Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of Takeda Pharmaceutical's Fazirsiran sodium?
Fazirsiran sodium is an antisense rnai oligonucleotide commercialized by Takeda Pharmaceutical, with a leading Phase III program in Alpha-1 Antitrypsin...
Data Insights
Risk adjusted net present value: What is the current valuation of Arrowhead Pharmaceuticals's Fazirsiran sodium?
Fazirsiran sodium is an antisense rnai oligonucleotide commercialized by Arrowhead Pharmaceuticals, with a leading Phase III program in Alpha-1 Antitrypsin...